Hepatitis B Surface Antigen (Hbsag) Decrease and Serum Interferon-Inducible Protein-10 Levels as Predictive Markers for Hbsag Loss during Treatment with Nucleoside/Nucleotide Analogues - Concepedia

Concepedia

Publication | Closed Access

Hepatitis B Surface Antigen (Hbsag) Decrease and Serum Interferon-Inducible Protein-10 Levels as Predictive Markers for Hbsag Loss during Treatment with Nucleoside/Nucleotide Analogues

86

Citations

36

References

2011

Year

Jerzy Jaroszewicz, Huy Ho, Antoaneta A. Markova, Katja Deterding, Karsten Wursthorn, Sandra Schulz, C.–Thomas Bock, Hans L. Tillmann, Michael P. Manns, Heiner Wedemeyer,

Antiviral Therapy

Abstract

Monitoring qHBsAg after successful HBV DNA suppression might be useful to identify patients who clear HBsAg, implicating finite NA treatment. The role of IP-10 as predictive marker for HBsAg loss should be further evaluated.

References

	Year	Citations

Page 1